摘要
目的:观察参麦注射液联合化疗治疗晚期结肠癌的临床效果。方法:选取晚期结肠癌患者80例,采用随机对照法分为对照组和观察组两组,每组各40例。对照组给予XELOX(卡培他滨+奥沙利铂)化疗方案治疗,观察组在对照组治疗方案的基础上再联合应用参麦注射液治疗。比较两组的临床疗效及毒副反应发生率。结果:观察组的治疗有效率及疾病控制率均明显高于对照组(P<0.05);观察组中性粒细胞减少、血小板减少、恶心、呕吐发生率均低于对照组(P<0.05)。结论:晚期结肠癌患者采用参麦注射液联合化疗治疗,可有效提高临床疗效,降低化疗毒副反应的发生率。
Objective To investigate the clinical effect of Shenmai injection combined with chemotherapy in the treatment of advanced colon cancer.Methods Eighty patients with advanced colon cancer were randomly divided into control group and observation group,with 40 cases in each group.The control group was treated with XELOX(capecitabine+oxaliplatin)chemotherapy,and the observation group was combined with Shenmai injection on the basis of the control group.The clinical efficacy and incidence of side effects were compared between the two groups.Results The treatment efficiency and disease control rate of the observation group were significantly higher than the control group(P<0.05).The incidence of neutropenia,thrombocytopenia,nausea and vomiting in the observation group were lower than those in the control group(P<0.05).Conclusion Shenmai injection combined with chemotherapy in patients with advanced colon cancer can effectively improve clinical efficacy and reduce the incidence of chemotherapy side effects.
作者
张权
张爱萍
ZHANG Quan;ZHANG Aiping(Second People’s Hospital of Jiaozuo City,Henan Province,Jiaozuo 454000,China)
出处
《中国民族民间医药》
2019年第8期85-87,共3页
Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词
结肠癌
化疗
参麦注射液
卡培他滨
奥沙利铂
Colon Cancer
Chemotherapy
Shenmai Injection
Capecitabine
Oxaliplatin
